Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Sphenopalatine Ganglion Blockade as a Non-invasive, Opioid-sparing Treatment for Headaches Following Aneurysmal Subarachnoid Hemorrhage

NCT07116408 is registered in ClinicalTrials.gov with Wright State University as lead sponsor.

NCT NCT07116408
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07116408 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Sphenopalatine Ganglion Blockade as a Non-invasive, Opioid-sparing Treatment for Headaches Following Aneurysmal Subarachnoid Hemorrhage
Lead sponsor
Wright State University
Phase
Phase 4
Overall status
Recruiting
Start date
May 20, 2024
Completion date
May 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysmal subarachnoid hemorrhage (asah), headache